{"disease":{"id":"esophageal-squamous-cell-carcinoma-by-ajcc-v8-stage","name":"esophageal squamous cell carcinoma by ajcc v8 stage"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06010303","title":"A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":118,"lead_sponsor_name":"BeiGene","has_results":false},{"nct_id":"NCT04006041","title":"Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":44,"lead_sponsor_name":"Jianhua Fu","has_results":false},{"nct_id":"NCT05449483","title":"Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}